The ERC-CFAR — the only CFAR in New York and one of 19 current NIH-funded CFARs nationwide — was established in 2017 to bring together researchers at Albert Einstein College of Medicine, The Rockefeller University, and The City University of New York Graduate School of Public Health and Health Policy (CUNY) to realize the ultimate goal of living in a world without AIDS. For this purpose, the center supports studies involving more than 150 independent investigators focused on four areas: lowering the incidence of HIV; developing next-generation HIV therapies; discovering a cure for HIV; and treating HIV-related comorbidities, coinfections and complications.
Albert Einstein College of Medicine Receives $11.3M NIH Grant to Expand the Einstein-Rockefeller-CUNY Center for AIDS Research
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally and internationally.
A key challenge is getting these medications to the people who need them. This is an important issue we need to address among those from historically marginalized groups, particularly Black and Hispanic Americans, who are disproportionately affected by this epidemic.